2020-11-12T12:37:26-06:00 2019-12-31 ERNST & YOUNG US LLP 111 MONUMENT CIRCLE SUITE 4000 INDIANAPOLIS IN 46204 990 2019-01-01 131924236 Memorial Sloan-Kettering Cancer Center % MARK K SVENNINGSON MEMO 6462273092 1275 YORK AVENUE NEW YORK NY 100656007 MARK K SVENNINGSON SVP FINANCE 6462273092 2020-11-11 true JENNIFER D RHODERICK P00395735 3176817000 173.68.23.158 35057220203175000020 2020-11-12 P 3D8A7F09343B9726AB15B70088DB3F617EF8B275 047C777BBD395ADD529156C75D94AFF56594489C 2019 2021-01-29 14:40:06Z CRAIG THOMPSON MD 1275 YORK AVENUE NEW YORK NY 100656007 1276383000 false 3475 X WWW.MSKCC.ORG X 1960 NY LEADERSHIP IN THE PREVENTION, TREATMENT, AND CURE OF CANCER THROUGH EXCELLENCE, VISION, AND COST EFFECTIVENESS IN PATIENT CARE, OUTREACH PROGRAMS, RESEARCH, AND EDUCATION 29 27 23338 770 -11619294 -13657689 169497434 31560247 679144000 780384000 191805000 157350000 27298566 29872753 1067745000 999167000 1000000 0 0 0 452355050 513567022 0 0 74650996 405217950 479016978 858573000 992584000 209172000 6583000 5241684000 5721273000 3164525000 3561984000 2077159000 2159289000 X MEMORIAL SLOAN-KETTERING CANCER CENTER IS DEDICATED TO THIS MISSION: LEADERSHIP IN THE PREVENTION, TREATMENT, AND CURE OF CANCER THROUGH EXCELLENCE, VISION, AND COST-EFFECTIVENESS IN PATIENT CARE, OUTREACH PROGRAMS, RESEARCH, AND EDUCATION. false false 829867936 773394000 MEMORIAL SLOAN-KETTERING CANCER CENTER PROVIDES THE FOLLOWING SERVICES TO ITS AFFILIATED ORGANIZATIONS: FINANCIAL ADMINISTRATION, EXECUTIVE MANAGEMENT, HUMAN RESOURCES, FACILITY MANAGEMENT, GENERAL AND ENVIRONMENTAL SERVICES, PROCUREMENT, PUBLIC AFFAIRS, RESEARCH TECHNOLOGY MANAGEMENT, CORPORATE COMPLIANCE, INFORMATION SYSTEMS AND TECHNOLOGY, AND INVESTMENT MANAGEMENT. IN ADDITION, CERTAIN SERVICES ARE PROVIDED ON A REQUISITION BASIS INCLUDING FOOD AND DIETARY SERVICES, FACILITIES MANAGEMENT (LOCKSMITH, ELECTRICIAN, PLUMBING, PAINTING AND CARPENTRY, ETC.) MEDICAL LIBRARY, CONFERENCE PLANNING, OCCUPANCY OF LEASED SPACE, TRANSPORTATION, IMMIGRATION SERVICES, MEDICAL ILLUSTRATION, MOTION MEDIA, SECURITY SERVICES SUCH AS INSTALLING ANTITHEFT DEVICES AND MAILROOM SERVICES. 12498414 MSKCC PAYS FEES TO CORNELL MEDICAL CENTER AND OTHER MEDICAL INSTITUTIONS FOR STAFF TO FURTHER THEIR SCIENTIFIC EDUCATION. IN ADDITION, THE CENTER HOSTS A NUMBER OF SYMPOSIUMS, SOME OF WHICH ARE OPEN TO THE PUBLIC. 24467875 20734000 CAFETERIA: THE CENTER OPERATES A CAFETERIA IN THE MAIN BUILDING COMPLEX WHERE VISITORS AND PATIENTS CAN PURCHASE MEALS AND SNACKS. SOCIETY OF MSKCC: THE SOCIETY OF MEMORIAL SLOAN-KETTERING CANCER CENTER, FOUNDED IN 1946, IS A VOLUNTEER ORGANIZATION DEDICATED TO PROMOTING THE WELL-BEING OF PATIENTS, SUPPORTING CANCER RESEARCH AND PROVIDING PUBLIC EDUCATION ON THE PREVENTION, EARLY DETECTION AND TREATMENT OF CANCER. THE COSTS SHOWN HERE ARE EXCLUSIVE OF FUNDRAISING ACTIVITIES, WHICH ARE REPORTED IN PART IX, COLUMN D. EXPENSE REVENUE CAFETERIA $ 9,169,820 $ 6,990,000 SOCIETY $ 4,017,055 $ 0 PCCTC $11,281,000 $13,744,000 TOTALS $24,467,875 $20,734,000 866834225 true true false true false false false false false true true true false false true false false true false true true false false false true false false false false true true false false false false false false false false false true true false false false true true true true false false true 1648 0 true 23338 true true true false false false false true true false false false false true false X 29 27 true false false false false false false true true false false false true true true true true true true true true AL AK AZ AR CA CO CT DE DC FL GA HI ID IL IN IA KS KY LA ME MD MA MI MN MS MO MT NE NV NH NJ NM NY NC ND OH OK OR PA PR RI SC SD TN TX UT VT VA WA WV WI WY X X MARK K SVENNINGSON 6462273414 633 THIRD AVENUE New York NY 10017 CRAIG THOMPSON MD BOARD MBR, PRESIDENT & CEO 50.0 0.0 X X 5507075 0 245034 KATHRYN MARTIN COO 50.0 0.0 X 2085542 0 557904 JASON KLEIN SVP & CHIEF INVESTMENT OFFICER 50.0 0.0 X 1667313 0 65803 MICHAEL P GUTNICK EVP & CFO until 9/2019 50.0 0.0 X 1564117 0 54349 JORGE LOPEZ ESQ EVP & GENERAL COUNCEL 50.0 0.0 X 1541870 0 76458 EDWARD MAHONEY SVP, FACILITIES MGMT & CONST 50.0 0.0 X 1058031 0 353598 KENNETH MANOTTI VP DEVELOPMENT 50.0 0.0 X 1313758 0 67372 DEBRA BERNS ESQ SVP & SR RISK OFFICER 50.0 0.0 X 1099203 0 41991 MICHAEL HARRINGTON evp & CFO effective 6/2019 50.0 0.0 X 1074016 0 51028 KERRY BESSEY SVP & CHIEF HR OFFICER 50.0 0.0 X 1059647 0 59040 GREGORY RASKIN VP, TECHNOLOGY DEVELOPMENT 50.0 0.0 X 1039054 0 68585 PATRICIA C SKARULIS SVP CH INFO OFF until 12/2019 50.0 0.0 X 1070264 0 36277 ERIC M COTTINGTON SVP, RESEARCH & TECH MGMT 50.0 0.0 X 1013804 0 67845 WENDY PERCHICK SVP STRATEGIC PLANNING & INNOV 50.0 0.0 X 998512 0 46732 MARK SVENNINGSON SVP FINANCE, CONTROLLER 50.0 0.0 X 961542 0 56522 LARRY NORTON SVP 50.0 0.0 X 903375 0 45341 JAMES HARDEN svp strategic partnerships 50.0 0.0 X 775052 0 67616 CLAUS JENSON evp ch digital off eff 10/2019 50.0 0.0 X 552876 0 263097 ANTHONY DIASIO VP Finance 50.0 0.0 X 709555 0 38578 AVICE MEEHAN SVP CH COMM OFF until 5/2019 50.0 0.0 X 595147 0 43106 CAROLYN LEVINE ESQ DEPUTY GEN COUNSEL CORP SECTY 50.0 0.0 X 518512 0 54998 RICHARD I BEATTIE BOARD MEMBER 1.0 0.0 X 0 0 0 IAN COOK BOARD MEMBER 2.0 0.0 X 0 0 0 STANLEY F DRUCKENMILLE BOARD MEMBER 1.0 0.0 X 0 0 0 ANTHONY B EVNIN BOARD MEMBER 1.0 0.0 X 0 0 0 ROGER W FERGUSON BOARD MEMBER 1.0 0.0 X 0 0 0 WILLIAM E FORD BOARD MEMBER 1.0 0.0 X 0 0 0 RICHARD N FOSTER BOARD MEMBER 1.0 0.0 X 0 0 0 STEPHEN FRIEDMAN BOARD MEMBER 1.0 0.0 X 0 0 0 ELLEN V FUTTER BOARD MEMBER 1.0 0.0 X 0 0 0 LOUIS V GERSTNER JR BOARD MEMBER 1.0 0.0 X 0 0 0 JONATHAN N GRAYER BOARD MEMBER 1.0 0.0 X 0 0 0 BENJAMIN W HEINEMAN J BOARD MEMBER 1.0 0.0 X 0 0 0 DAVID H KOCH BOARD MEMBER UNTIL 8/2019 1.0 0.0 X 0 0 0 MARIE-JOSEE KRAVIS VICE CHAIR OF THE BOARD 2.0 0.0 X 0 0 0 JAMIE C NICHOLLS VICE CHAIR OF THE BOARD 2.0 0.0 X 0 0 0 JAMES G NIVEN BOARD MEMBER 1.0 0.0 X 0 0 0 BRUCE C RATNER BOARD MEMBER 1.0 0.0 X 0 0 0 ALEXANDER T ROBERTSON BOARD MEMBER 1.0 0.0 X 0 0 0 JAMES D ROBINSON III BOARD MEMBER 2.0 0.0 X 0 0 0 VIRGINIA M ROMETTY BOARD MEMBER 1.0 0.0 X 0 0 0 STEPHEN C SHERRILL BOARD MEMBER 1.0 0.0 X 0 0 0 PETER J SOLOMON BOARD MEMBER 1.0 0.0 X 0 0 0 JOHN R STRANGFELD BOARD MEMBER 1.0 0.0 X 0 0 0 PETER A WEINBERG BOARD MEMBER 1.0 0.0 X 0 0 0 DEBORAH C WRIGHT BOARD MEMBER UNTIL 4/2019 1.0 0.0 X 0 0 0 SCOTT M STUART CHAIR OF THE BOARD 1.0 0.0 X 0 0 0 CLIFTON S ROBBINS BOARD MEMBER & TREASURER 1.0 0.0 X X 0 0 0 NORMAN C SELBY BOARD MBR & SEC UNTIL 4/2019 2.0 0.0 X X 0 0 0 DOUGLAS A WARNER III HONORARY CHAIR OF THE BOARD 1.0 0.0 X X 0 0 0 HENRY A FERNANDEZ BOARD MEMBER EFFECTIVE 4/2019 1.0 0.0 X 0 0 0 ALAN D SCHNITZER BOARD MEMBER EFFECTIVE 4/2019 1.0 0.0 X 0 0 0 27108265 0 2361274 1036 false true false TURNER CONSTRUCTION 375 HUDSON STREET NEW YORK NY 10014 GENERAL CONSTRUCTION 130568969 WORTHINGTON ENERGY 445 HUTCHINSON STREET COLUMBUS OH 43235 GENERAL CONSTRUCTION 63227818 HUNTER ROBERTS CONSTRUCTION GR LLC 2 WORLD FINANCIAL CENTER NEW YORK NY 10001 GENERAL CONSTRUCTION 28401902 JGN CONSTRUCTION CORP 66-40 69TH STREET MIDDLE VILLAGE NY 11379 GENERAL CONSTRUCTION 20881151 LEND LEASE US CONSTRUCTION 200 PARK AVENUE NEW YORK NY 10166 GENERAL CONSTRUCTION 10416263 199 X 4328247 27232000 1547236 31560247 SERVICES PROVIDED SEE NOTE A & ATTACH.1 IN SCH O 900099 773394000 773394000 CAFETERIA 721000 6990000 6990000 780384000 55236000 -11619294 66855294 1502000 1502000 2044000 2044000 0 0 0 376747000 276135000 100612000 100612000 100612000 320989 4328247 1081000 -760011 -760011 0 0 0 0 0 0 RESEARCH EXPENSE RECOVERY 711110 13744000 13744000 GIFT SHOP INCOME 811000 571000 571000 VENDOR DISCOUNT 900099 1131000 1131000 13142764 13142764 28588764 999167000 794128000 -11619294 185098047 0 0 0 0 26713079 22248478 2951153 1513448 0 371484558 337170471 7604616 26709471 33334302 30636891 904652 1792759 55426286 48813099 1091528 5521659 26608797 24452315 722033 1434449 0 19467583 18260969 1085893 120721 1637700 1508652 128149 899 921757 921757 0 7286493 7286493 76714480 63477429 5936942 7300109 21793965 20840317 953648 130725819 98942712 7138051 24645056 45343890 45071103 272787 960455 960455 29199577 28806890 252955 139732 2435214 1685880 221535 527799 0 5346740 4767531 47952 531257 14819683 7040324 7779359 0 70800797 65234456 4325173 1241168 2090254 1937597 26116 126541 NET REQUISITIONED SERVICES 36633429 32525244 1094272 3013913 FUNDRAISING EVENTS -1080514 -1080514 UBIT EXPENSE 31932 31932 PHARMACEUTICALS 513424 512296 1128 13374300 11979814 1235605 158881 992584000 866834225 51098779 74650996 X 14025372 6369682 7655690 5479000 7270000 548854000 595898000 123112000 82969000 1005883000 848927000 0 0 0 0 38362000 56272000 624000 659000 95865000 154884000 1228158000 596364000 369390000 631794000 2506590000 2478439000 547525000 864161000 0 0 0 0 0 0 5241684000 5721273000 423085000 427496000 0 0 0 0 1051371000 1205671000 0 0 0 0 0 0 1350000000 1388602000 340069000 540215000 3164525000 3561984000 X 1771943000 1840827000 305216000 318462000 2077159000 2159289000 5241684000 5721273000 X 6583000 321736000 -246189000 X false true X true false X 51108585 67090737 34535000 169497434 31560247 353792003 0 0 51108585 67090737 34535000 169497434 31560247 353792003 78885769 274906234 63076697 26432410 47403556 90780000 70401294 298093957 0 0 651885960 2492314447 0.42171 0.45481 X PART I, LINE 3 THE INTERNAL REVENUE SERVICE HAS DETERMINED THAT MEMORIAL SLOAN-KETTERING CANCER CENTER QUALIFIES AS A PUBLIC CHARITY UNDER SECTION 170 (B) (1) (A) (iii). HOWEVER, SINCE IT DOES NOT OPERATE A HOSPITAL, IT IS NOT REQUIRED TO COMPLETE SCHEDULE H. RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED X 921757 921757 921757 921757 991662243 5258339243 992584000 5259261000 1000000 1000000 250000 250000 1000000 1000000 1000000 1000000 4000000 6000000 896016 793599 872735 921757 3484107 250000 250000 250000 250000 1000000 1500000 PART II-A ALL LOBBYING ACTIVITIES ARE PERFORMED BY MEMORIAL SLOAN-KETTERING CANCER CENTER (EIN 13-1924236). LOBBYING EXPENDITURES ARE EXPENSED BY THE CENTER AND ARE REPORTED ON THE STATEMENT OF FUNCTIONAL EXPENSE LINE 11d. THE CENTER HAS MADE THE 501(h) ELECTION. OUR AFFILIATED ORGANIZATIONS ARE IDENTIFIED BELOW. ALL AFFILIATES USE THE CORPORATE ADDRESS 1275 YORK AVENUE, NEW YORK, N.Y. 10065-6007. MEMORIAL HOSPITAL FOR CANCER AND ALLIED DISEASES (13-1624082), SLOAN-KETTERING INSTITUTE FOR CANCER RESEARCH (13-1624182), SKI REALTY, INC. (13-3389586), LOUIS V. GERSTNER JR., GRADUATE SCHOOL (20-2212588), MSK. INSURANCE U.S., INC. (83-0363317), AND MSKCC PROTON INC., (35-2397819). 385622000 10435000 394000 396451000 250120000 139261000 -3759000 385622000 217145357 20320000 12654643 250120000 211696215 13020 5436122 217145357 213471000 19530 -1794315 211696215 0.53140 0.46860 false false 356347000 86046000 270301000 21888000 17902000 3986000 677730000 492416000 185314000 172193000 172193000 631794000 PRIVATE EQUITY & VENTURE CAP 864161000 F 864161000 0 PENSION AND POSTRETIREMENT 415714000 DEFERRED GIFT ANNUITY 18917000 ASSET RETIREMENT OBLIGATION 3156000 INSURANCE RESERVES 27000 CAPTIVE INSURANCE LOAN AGREEME 101799000 ACCRUED SICK PAY 602000 540215000 1306086000 321736000 1081000 322817000 983269000 15898000 15898000 999167000 977767000 1081000 1081000 976686000 15898000 15898000 992584000 INTENDED USE OF ENDOWMENT FUNDS PERMANENT ENDOWMENT FUNDS ARE HELD BY THE ORGANIZATION IN PERPETUITY. INCOME EARNED ON THE FUND BALANCE IS USED TO SUPPORT THE OPERATIONS OF MEMORIAL SLOAN-KETTERING CANCER CENTER. FIN 48 LIABILITY FOR UNCERTAIN TAX POSITIONS A FIN 48 FOOTNOTE DISCLOSURE, RELATING TO THE ACCOUNTING FOR INCOME TAXES, WAS NOT REQUIRED BECAUSE THERE WAS NO MATERIAL IMPACT ON THE INSTITUTION'S FINANCIAL STATEMENTS. OTHER RECONCILING ITEMS lines 2d DIRECT EXPENSES RELATING TO FUNDRAISING EVENTS ARE REMOVED FROM THE FUNCTIONAL EXPENSES AND NETTED ON THE STATEMENT OF REVENUE $1,081,000. Europe (Including Iceland and Greenland) Program Services INVESTMENT MEETINGS 88444 East Asia and the Pacific Program Services INVESTMENT MEETINGS 64181 North America Program Services INVESTMENT MEETINGS 2189 South Asia Program Services INVESTMENT MEETINGS 1978 South America Program Services INVESTMENT MEETINGS 1764 Europe (Including Iceland and Greenland) 2 Program Services ADMINISTRATIVE SUPPORT 298821 Central America and the Caribbean Investments 2187515991 Europe (Including Iceland and Greenland) Investments 40593159 Sub-Saharan Africa Investments 15985713 2 2 2244552240 2244552240 true false true true true false Organization's Procedures for Monitoring Use of Grant Funds Outside the US MEMORIAL SLOAN-KETTERING CANCER CENTER DOES NOT MAKE GRANTS OR USE GRANT MONEY OUTSIDE THE UNITED STATES. SCHEDULE F, PART I , LINE 3, COLUMN f VALUES SHOWN IN COLUMN F ARE THE MARKET VALUES FOR THE INVESTMENTS AT DECEMBER 31. All States SPRING BALL 1783383 1721383 62000 125325 3700 135466 FALL PARTY 671359 596219 75140 86095 57948 4 2194494 2010645 183849 288751 111823 59401 212491 4649236 4328247 320989 374846 237148 63101 405905 1081000 -760011 X X true true X X X X X true true false false false false false true true true CRAIG THOMPSON MD BOARD MBR, PRESIDENT & CEO 1793875 3330000 383200 22400 222634 5752109 17500 KERRY BESSEY SVP & CHIEF HR OFFICER 680987 337190 41470 22400 36640 1118687 17500 ERIC M COTTINGTON SVP, RESEARCH & TECH MGMT 648570 325500 39734 22400 45445 1081649 17500 MICHAEL P GUTNICK EVP & CFO until 9/2019 810810 708022 45285 22400 31949 1618466 17500 JASON KLEIN SVP & CHIEF INVESTMENT OFFICER 941978 692260 33075 22400 43403 1733116 17500 CAROLYN LEVINE ESQ DEPUTY GEN COUNSEL CORP SECTY 423283 84000 11229 29885 25113 573510 6514 JORGE LOPEZ ESQ EVP & GENERAL COUNCEL 916199 544690 80981 30900 45558 1618328 8750 EDWARD MAHONEY SVP, FACILITIES MGMT & CONST 580602 437850 39579 322400 31198 1411629 17500 KATHRYN MARTIN COO 1376048 676550 32944 522400 35504 2643446 17500 AVICE MEEHAN SVP CH COMM OFF until 5/2019 241826 88540 264781 15890 27216 638253 8385 PATRICIA C SKARULIS SVP CH INFO OFF until 12/2019 343495 709269 17500 22400 13877 1106541 17500 MICHAEL HARRINGTON evp & CFO effective 6/2019 748383 300000 25633 30900 20128 1125044 WENDY PERCHICK SVP STRATEGIC PLANNING & INNOV 647367 319450 31695 22400 24332 1045244 17500 MARK SVENNINGSON SVP FINANCE, CONTROLLER 658974 262650 39918 22400 34122 1018064 17500 GREGORY RASKIN VP, TECHNOLOGY DEVELOPMENT 553863 475000 10191 30900 37685 1107639 8750 ANTHONY DIASIO VP Finance 518503 178500 12552 30900 7678 748133 8750 LARRY NORTON SVP 863620 0 39755 900 44441 948716 8750 JAMES HARDEN svp strategic partnerships 548422 217880 8750 30900 36716 842668 8750 DEBRA BERNS ESQ SVP & SR RISK OFFICER 550032 540000 9171 30900 11091 1141194 7020 KENNETH MANOTTI VP DEVELOPMENT 857609 425000 31149 30900 36472 1381130 8750 CLAUS JENSON evp ch digital off eff 10/2019 152388 400000 488 257692 5405 815973 SUPPLEMENTAL COMPENSATION INFORMATION SCHEDULE J, PART I, LINE 1A BUSINESS OR FIRST-CLASS TRAVEL IS ALLOWED FOR FLIGHTS GREATER THAN SIX CONTINUOUS HOURS FOR ANY EMPLOYEE NOT FUNDED BY FEDERAL GRANTS. EXCEPTIONS TO THE SIX HOUR RULE ARE REVIEWED ON AN INDIVIDUAL BASIS. ALL TRAVEL MUST BE APPROVED BEFORE ANY ARRANGEMENTS ARE MADE. MSKCC HAS AN ACCOUNTABLE TRAVEL POLICY AND THEREFORE, DOES NOT INCLUDE TRAVEL AS TAXABLE COMPENSATION. THE DUTIES TO BE PERFORMED BY OUR PRESIDENT REQUIRE HIM TO BE ON CALL AND TO PERFORM DUTIES AS AND WHEN APPROPRIATE DURING HIS OFF-DUTY PERIODS AS WELL AS DURING NORMAL OFFICE HOURS. AN EMPLOYMENT CONTRACT REQUIRES OUR PRESIDENT TO LIVE IN THE OFFICIAL RESIDENCE OWNED AND MAINTAINED BY THE INSTITUTION. THE CONTRACT REQUIRES OUR PRESIDENT TO USE THE RESIDENCE FOR INSTITUTIONAL PURPOSES, INCLUDING, BUT NOT LIMITED TO, MEETINGS WITH STAFF, DONORS AND POTENTIAL DONORS, VISITING PROFESSORS AND SCIENTISTS, AND OTHER PERSONS INVOLVED WITH THE AFFAIRS OF THE INSTITUTION, CONFIDENTIAL INTERVIEWS WITH MEMBERS AND PROSPECTIVE MEMBERS OF THE STAFF; AND FOR OTHER INSTITUTIONAL ACTIVITIES CONDUCTED DURING AND OUTSIDE OF NORMAL OFFICE HOURS. THE COST IS REPORTED AS COMPENSATION ON FORM 990 AND IS EXCLUDED FROM TAXABLE COMPENSATION IN ACCORDANCE WITH CODE SECTION 119. SCHEDULE J, PART I LINE 4A-INCLUDED IN FORM 990 IS SEVERANCE PAY FOR AVICE MEEHAN, SVP & CHIEF COMMUNICATION OFFICER, OF $254,302 TERMINATED IN MAY 2019 LINE 4B - THE INSTITUTION MAINTAINS A NONQUALIFIED DEFERRED COMPENSATION PLAN WHICH IS USED FOR EMPLOYER CONTRIBUTIONS IN EXCESS OF THOSE ALLOWED BY THE RETIREMENT PLAN. LINE 7 - INCENTIVE PAY IS PROVIDED TO OFFICERS AND KEY EMPLOYEES BASED ON THEIR ACHIEVEMENT OF PRE-DETERMINED GOALS RELATING TO QUALITY OF CARE, PATIENT SAFETY, OPERATIONAL EFFICIENCY AND FINANCIAL PERFORMANCE. THE COMPENSATION COMMITTEE OF THE BOARD AUTHORIZES ALL EXECUTIVE BONUSES AND INCENTIVE PLANS ON AN ANNUAL BASIS. IN ADDITION, AS WELL AS AN OVERALL AUTHORIZATION AND APPROVAL FOR KEY EMPLOYEES AND OTHER MANAGEMENT INCLUDING PROFESSIONAL AND OTHER STAFF BY SETTING THE BONUS POOL IN CONJUNCTION WITH THE INPUT FROM HUMAN RESOURCES. STAFF BONUSES ARE IMPACTED BY ANNUAL MERIT REVIEW PROCESS. LINE 8 - AN EMPLOYMENT CONTRACT WAS ENTERED INTO AND SIGNED PRIOR TO EMPLOYMENT. A DORMITORY AUTHORITY OF THE STATE OF NEW YORK 146000293 649906RK2 2012-02-16 388814944 SEE PART VI true false false B DORMITORY AUTHORITY OF THE STATE OF NEW YORK 146000293 6499063Z7 2013-06-28 80000000 SEE PART VI false false false C DORMITORY AUTHORITY OF THE STATE OF NEW YORK 146000293 000000000 2016-04-28 110000000 SEE PART VI false false false D NEW JERSEY ECONOMIC DEVELOPMENT AUTHORITY 222045817 000000000 2016-09-09 145000000 SEE PART VI false false false A 11195000 287195000 389043483 0 9172031 0 2651698 0 0 92720595 284499159 0 2014 false true true true B 50000000 0 80000000 0 0 0 0 0 0 0 80000000 0 2013 true false true true C 11236077 0 110239999 0 0 0 155282 0 0 110009717 75000 0 2017 false false true true D 47125000 0 145000000 0 0 0 72861 0 0 144627139 300000 0 2018 false false true true A false false false true false 0.00000 0.00000 0.00000 false false 0.00000 false true B false false false true false 0.00000 0.00000 0.00000 false false 0.00000 false true C false false false true false 0.00000 0.00000 0.00000 false false 0.00000 false true D false false false true false 0.00000 0.00000 0.00000 false false 0.00000 false true A false false false true false false 0 false 0 false true B false false false true false false 0 false 0 false true C false true false false false false 0 false 0 false true D false true false false false false 0 false 0 false true A true B true C true D true PART I, COLUMN (F) DESCRIPTION OF PURPOSE 2012 & 2012-I SERIES BONDS - CUSIP #649906RK2: 2012 SERIES BONDS WERE USED TO CONSTRUCT AND EQUIP AN AMBULATORY FACILITY AND TO ADVANCE REFUND A PORTION OF THE 2003 SERIES BONDS ISSUED MAY 14, 2003. 2013 SERIES BONDS - CUSIP #6499063Z7: 2013 SERIES BONDS WERE USED TO CURRENT REFUND THE 2010 DASNY SERIES BONDS ISSUED 9/2/2010. 2016 SERIES BONDS (DASNY) - CUSIP #000000000 2016 DASNY SERIES BONDS WERE USED TO CONSTRUCT/RENOVATE AND UPGRADE AND EQUIP VARIOUS FACILITIES. 2016 SERIES BONDS (NJEDA) - CUSIP #000000000 2016 SERIES (NJEDA) BONDS WERE USED TO CONSTRUCT AND EQUIP VARIOUS FACILITIES. 2017 SERIES BONDS - CUSIP #000000000: 2017 SERIES BONDS WERE USED TO CURRENT REFUND THE 2015 SERIES BONDS ISSUED JULY 16, 2015 AND CONSTRUCT VARIOUS FACILITIES. 2019 SERIES BONDS - CUSIP #64990GVG4: 2019 SERIES BONDS WERE USED TO REIMBURSE EXPENDITURES INCURRED TO CONSTRUCT A PATIENT CARE FACILITY. PART II LINE 3 - THE AMOUNT OF PROCEEDS ON PART II LINE 3 IS DIFFERENT FROM PART I COLUMN (E) BECAUSE PART II LINE 3 INCLUDES INVESTMENT INCOME AND GAINS/LOSSES. PART III LINE 3(D) - ANY MANAGEMENT CONTRACTS AND RESEARCH AGREEMENTS THAT MAY RESULT IN PRIVATE BUSINESS USE OF BONDS FINANCED PROPERTIES ARE REVIEWED FIRST BY IN-HOUSE STAFF WHO ARE KNOWLEDGEABLE OF AND RESPONSIBLE FOR THE FORM 990. OUTSIDE COUNSEL IS CONSULTED IF QUESTIONS ARISE. PART IV LINE 2 - THE 2012 SERIES BONDS REBATE CALCULATIONS WERE LAST PERFORMED ON FEBRUARY 16, 2017. THE 2013 SERIES BONDS REBATE CALCULATIONS WERE LAST PERFORMED ON JUNE 21, 2019. A DORMITORY AUTHORITY OF THE STATE OF NEW YORK 146000293 000000000 2017-12-20 335567386 SEE PART VI false false false B DORMITORY AUTHORITY OF THE STATE OF NEW YORK 146000293 64990GVG4 2019-11-01 342248699 SEE PART VI false false false A 6395000 0 340233054 0 0 0 2262236 0 0 221486640 91432989 25051190 2019 true false true true B 0 0 342248699 0 0 0 2248699 0 0 340000000 0 0 2019 false false true true A false false false true false 0.00000 0.00000 0.00000 false false 0.00000 false true B false false false true false 0.00000 0.00000 0.00000 false false 0.00000 false true A false true false false false false 0 false 0 false true B false true false false false false 0 false 0 false true A true B true KING STREET CAPITAL MANAGEMENT SEE BELOW 650489 INVESTMENT MANAGEMENT FEES false BUSINESS TRANSACTIONS INVOLVING INTERESTED PERSONS MS. JAMIE NICHOLLS IS A BOARD MEMBER OF THE CENTER. HER SPOUSE IS A CO-FOUNDER OF KING STREET CAPITAL MANAGEMENT. DURING 2019, THE CENTER PAID KING STREET $473,747 IN MANAGEMENT FEES. DURING 2019, CARRIED INTERST WAS $176,742. MSK GAVE A REDEMPTION NOTICE AT THE END OF 2018, and PURSUANT TO standard redemption terms, MAINTAINED A SMALL AND DECLINING EXPOSURE TO KING STREET THROUGHOUT 2019 AND 2020. The Institution invested in King Street prior to Ms. Nicholls joining the Board of Memorial Sloan Kettering Cancer Center. MS. NICHOLLS WAS NOT A PARTY TO THE TRANSACTION. THERE IS NO SHARING OF THE CENTER'S REVENUE. THE PURCHASES OF GOODS AND SERVICES BY THE CENTER WERE MADE IN THE ORDINARY COURSE OF BUSINESS, AT COMMERCIALLY AVAILABLE RATES normally charged to others. X 195 1547236 MARKET VALUE false true false SALE OF NON CASH CONTRIBUTIONS EXCLUDED FROM THIS VALUE ARE PLEDGE PAYMENTS, MADE BY STOCK, TOTALING $91,629. PROMISES TO GIVE ARE REPORTED AT THE DATE THE INTENT IS MADE IN WRITING. PUBLICLY TRADED DONATED STOCK IS SOLD BY MERRILL LYNCH ON BEHALF OF MEMORIAL SLOAN-KETTERING CANCER CENTER. NOTE A - AFFILIATED ORGANIZATIONS MEMORIAL SLOAN-KETTERING CANCER CENTER (THE CENTER) IS AFFILIATED WITH THE FOLLOWING 501 (C) (3) ORGANIZATIONS: SLOAN-KETTERING INSTITUTE FOR CANCER RESEARCH (THE INSTITUTE), MEMORIAL HOSPITAL FOR CANCER AND ALLIED DISEASES (THE HOSPITAL), S.K.I. REALTY, INC., MSK INSURANCE US, INC., THE LOUIS V. GERSTNER JR., GRADUATE SCHOOL OF BIOMEDICAL SCIENCES, MSKCC PROPERTIES LLC, WITH THE HOSPITAL BEING THE SOLE MEMBER, THE PROSTATE CANCER CLINICAL TRIALS CONSORTIUM (PCCTC) AND MSKCC PROTON INC. WITH THE CENTER BEING THE SOLE MEMBER. THE ORGANIZATIONS SHARE CERTAIN FACILITIES AND VARIOUS SERVICES INCLUDING ADMINISTRATIVE, PLANT AND ANCILLARY SERVICES. THE FOLLOWING IS A SUMMARY OF SUCH SERVICES IN 2019: SERVICES PROVIDED TO THE CENTER BY: THE HOSPITAL $ 12,846,000 THE INSTITUTION $ 8,592,000 S.K.I. REALTY, INC. $ 15,194,000 TOTAL $ 36,632,000 SERVICES PROVIDED BY THE CENTER TO: THE HOSPITAL $605,611,000 THE INSTITUTION $161,774,000 S.K.I. REALTY, INC. $ 4,598,000 GERSTNER GRADUATE SCHOOL $ 84,000 PROSTATE CANCER CLINICAL TRIALS $ 1,327,000 TOTAL $773,394,000 MEMORIAL SLOAN-KETTERING CANCER CENTER AND ITS AFFILIATES ARE COLLECTIVELY REFERRED TO AS "THE ORGANIZATION". THE CENTER CARRIES ON FUNDRAISING ACTIVITIES ON ITS OWN BEHALF AND ON BEHALF OF THE AFFILIATES. CONTRIBUTIONS AND PLEDGES ARE RECORDED BASED ON THE DONOR'S INTENT IN THE RECORDS OF THE APPROPRIATE ENTITY. FOR 2019, TOTAL CONTRIBUTIONS AND PLEDGES RAISED ON BEHALF OF THE CENTER, HOSPITAL, INSTITUTE AND GRADUATE SCHOOL WERE $254,400,000. CONTRIBUTORS' INFORMATION PROVIDED IN THE ATTACHED SCHEDULE B REPRESENTS THE DONORS' TOTAL PHILANTHROPIC CONTRIBUTIONS TO THE CENTER ONLY. IF ANY DONOR LISTED ON SCHEDULE B MADE CONTRIBUTIONS TO THE HOSPITAL, INSTITUTE, OR GRADUATE SCHOOL, THOSE CONTRIBUTIONS WOULD NOT BE REFLECTED ON THE ATTACHED SCHEDULE B. FUNDRAISING EXPENSES OF $74,650,996 WERE INCURRED AND REPORTED BY THE CENTER IN PART IX, STATEMENT OF FUNCTIONAL EXPENSES. THE CENTER IS ALSO INVOLVED IN LOBBYING FOR THE HOSPITAL AND INSTITUTE, SEE SCHEDULE C. PART II-A. FORM 990, PART VI, LINE 2 FOR THE TAX YEAR 2019, THE FOLLOWING BUSINESS RELATIONSHIPS WERE REPORTED: 1. DIRECTORS ELLEN V. FUTTER, LOUIS V. GERSTNER JR. AND PETER J. SOLOMON 2. DIRECTORS NORMAN C. SELBY, STANLEY F. DRUCKENMILLER, ALEXANDER T. ROBERTSON AND OFFICER ERIC M. COTTINGTON PHD. 3. DIRECTORS ANTHONY B. EVNIN AND NORMAN C. SELBY 4. DIRECTORS ELLEN V. FUTTER AND RICHARD I. BEATTIE FORM 990, PART VI, LINE 11B PRIOR TO FILING THE RETURN, A REVIEW OF THE 990 WAS CONDUCTED BY THE SR. VICE PRESIDENT OF FINANCE AND THE CHIEF FINANCIAL OFFICER. IN ADDITION, FORM 990 IS PREPARED IN CONJUNCTION WITH ERNST AND YOUNG, LLP. FORM 990, PART VI, LINE 12C IN 2019, MSK ADOPTED AND IMPLEMENTED AN ENHANCED CONFLICT OF INTEREST PROGRAM, INCLUDING REVISED CONFLICT OF INTEREST POLICIES AND PROCEDURES AND A NEW GOVERNANCE STRUCTURE. THE ENHANCED CONFLICT OF INTEREST PRACTICES IMPLEMENTED THROUGH THREE COMPREHENSIVE CONFLICT OF INTEREST POLICIES FOR MEMORIAL SLOAN KETTERING CANCER CENTER, MEMORIAL HOSPITAL FOR CANCER AND ALLIED DISEASES AND SLOAN-KETTERING INSTITUTE FOR CANCER RESEARCH, ARE OUTLINED BELOW: 1. CONFLICT OF INTEREST AND COMMITMENT POLICY (THE "INDIVIDUAL COI POLICY"). a. THE INDIVIDUAL COI POLICY APPLIED TO: (I) PHYSICIANS AND SCIENTISTS WITH ACADEMIC APPOINTMENTS AT ANY LEVEL; (II) ANY CLINICAL PROVIDER WHO COULD INDEPENDENTLY WRITE ORDERS OR PRESCRIPTIONS; (III) INDIVIDUALS WHOSE ROLES INCLUDED THE DESIGN, CONDUCT OR REPORTING OF RESEARCH AND/OR WERE ENGAGED IN HUMAN SUBJECT RESEARCH; (IV) ADMINISTRATIVE EMPLOYEES WITH INDEPENDENT AUTHORITY TO MAKE PURCHASING DECISIONS OR WHO WERE OTHERWISE ABLE TO BIND, NEGOTIATE ON BEHALF, OR EXECUTE AGREEMENTS ON BEHALF OF, MSK; AND (V) INDIVIDUALS THAT SERVED ON MSK INSTITUTIONAL COMMITTEES WITH RESPONSIBILITY FOR OVERSIGHT OF RESEARCH, FORMULARY, OR PURCHASING DECISIONS. b. MSK'S COMPLIANCE COI OFFICE ("COMPLIANCE") AND THE INSTITUTIONAL CONFLICT OF INTEREST COMMITTEE (THE "MSK COI COMMITTEE") WERE RESPONSIBLE FOR THE ADMINISTRATION OF THIS POLICY, UNDER THE OVERSIGHT OF THE NEWLY-CREATED COMMITTEE OF THE BOARD (THE "JOINT COI COMMITTEE") DEDICATED EXCLUSIVELY TO DISCHARGING THE BOARD'S RESPONSIBILITY AND AUTHORITY OVER MSK'S CONFLICTS OF INTEREST PROGRAM. c. UPON BECOMING COVERED BY THE INDIVIDUAL COI POLICY, ANNUALLY THEREAFTER AND/OR AS NEW SIGNIFICANT INTERESTS AROSE, AN INDIVIDUAL WAS REQUIRED TO DISCLOSE FINANCIAL INTERESTS AND EXTERNAL RELATIONSHIPS AND ACTIVITIES ("INTERESTS"), WHETHER PAID OR UNPAID, THAT REASONABLY APPEARED TO BE RELATED TO THE INDIVIDUAL'S INSTITUTIONAL RESPONSIBILITIES. COVERED PERSONS WERE REQUIRED TO DISCLOSE INTERESTS FOR THEMSELVES AND IMMEDIATE FAMILY MEMBERS. d. DEPENDING ON THE CIRCUMSTANCES AND BASED ON ESTABLISHED CRITERIA, DISCLOSED INTERESTS WERE REVIEWED BY COMPLIANCE, THE MSK COI COMMITTEE, MSK COI COMMITTEE DESIGNEE(S), AND/OR THE JOINT COI COMMITTEE TO DETERMINE WHETHER AN INDIVIDUAL CONFLICT OF INTEREST EXISTED OR PRESENTED THE PERCEPTION THEREOF (I.E. WHETHER AN INDIVIDUAL FINANCIAL INTEREST COULD DIRECTLY AND SIGNIFICANTLY IMPACT AN INDIVIDUAL'S INSTITUTIONAL RESPONSIBILITIES, OR AN INDIVIDUAL'S INTEREST COULD BE DIRECTLY AND SIGNIFICANTLY IMPACTED BY THEIR INSTITUTIONAL RESPONSIBILITIES). e. THE POLICY REQUIRED ANY INDIVIDUAL CONFLICT OF INTEREST TO BE MANAGED, REDUCED OR ELIMINATED. WHEN A CONFLICT OF INTEREST DETERMINATION WAS MADE, THE MSK COI COMMITTEE, THE MSK COI COMMITTEE DESIGNEE(S), OR THE JOINT COI COMMITTEE DETERMINED HOW TO ADDRESS IT. FOR THOSE CONFLICTS DEEMED MANAGEABLE, MANAGEMENT STRATEGIES IMPLEMENTED INCLUDED DISCLOSURE OF THE INTEREST IN RELEVANT PUBLICATIONS, PRESENTATIONS, CONSENT FORMS, AND EDUCATIONAL MATERIALS; RECUSAL AND/OR OTHER LIMITATION ON ROLE; INDEPENDENT OVERSIGHT BY A DISINTERESTED SENIOR PERSONNEL MEMBER OR COMMITTEE; AND TEMPORARY OR PERMANENT REDUCTION, DIVESTITURE, RELINQUISHMENT, OR TERMINATION OF AN INDIVIDUAL'S INTEREST. 2. INSTITUTIONAL CONFLICT OF INTEREST POLICY (THE "INSTITUTIONAL COI POLICY"). a. THE INSTITUTIONAL COI POLICY APPLIED TO FINANCIAL INTERESTS AND RELATIONSHIPS ("INTERESTS") HELD BY MSK AS AN INSTITUTION, AS WELL AS THOSE FINANCIAL INTERESTS AND RELATIONSHIPS ("INTERESTS") HELD BY FIVE SENIOR EXECUTIVE OFFICERS DEEMED "INSTITUTIONAL OFFICIALS,THEIR IMMEDIATE FAMILY MEMBERS. INSTITUTIONAL OFFICIALS INCLUDED THE PRESIDENT AND CHIEF EXECUTIVE OFFICER, THE PHYSICIAN-IN-CHIEF AND CHIEF MEDICAL OFFICER, THE CHIEF OPERATING OFFICER, THE CHIEF FINANCIAL OFFICER, AND THE DIRECTOR OF THE SLOAN-KETTERING INSTITUTE FOR CANCER RESEARCH. b. INSTITUTIONAL INTERESTS HELD BY MSK WERE MADE AVAILABLE TO COMPLIANCE THROUGH REGULAR REPORTS FROM AND ONGOING ENGAGEMENT WITH RELEVANT MSK DEPARTMENTS. INSTITUTIONAL INTERESTS HELD BY INSTITUTIONAL OFFICIALS WERE DISCLOSED THROUGH THE PROCESS DESCRIBED ABOVE IN THE INDIVIDUAL COI POLICY, AS WELL AS THE PROCESS DESCRIBED BELOW IN THE BOARD COI POLICY. c. THE MSK COI COMMITTEE OR MSK COI COMMITTEE DESIGNEE(S) WERE RESPONSIBLE FOR DETERMINING WHETHER AN INSTITUTIONAL CONFLICT OF INTEREST EXISTED; I.E. WHETHER THE INSTITUTIONAL INTEREST HELD BY MSK OR AN INSTITUTIONAL OFFICIAL (OR THEIR IMMEDIATE FAMILY MEMBERS) COULD, OR COULD REASONABLY BE PERCEIVED TO, DIRECTLY AND SIGNIFICANTLY AFFECT THE DESIGN, CONDUCT, REPORTING, REVIEW, OR OVERSIGHT OF MSK RESEARCH OR THE OUTCOME OF AN MSK ACTIVITY OR DECISION. d. THE POLICY REQUIRED ANY INSTITUTIONAL CONFLICT OF INTEREST TO BE MANAGED, REDUCED OR ELIMINATED. WHEN AN INSTITUTIONAL CONFLICT OF INTEREST DETERMINATION WAS MADE, THE MSK COI COMMITTEE AND/OR THE MSK COI COMMITTEE DESIGNEE(S) DETERMINED HOW TO ADDRESS IT. FOR THOSE CONFLICTS DEEMED MANAGEABLE, MANAGEMENT STRATEGIES IMPLEMENTED INCLUDED RECUSAL OF THE APPLICABLE INSTITUTIONAL OFFICIAL FROM DECISION-MAKING REGARDING THE ARRANGEMENT AND DISCLOSURE TO RELEVANT PERSONNEL; DISCLOSURE OF THE INTEREST IN RELEVANT PUBLICATIONS, PRESENTATIONS, CONSENT FORMS, AND EDUCATIONAL MATERIALS; INDEPENDENT OVERSIGHT BY A DISINTERESTED SENIOR PERSONNEL MEMBER OR COMMITTEE; AND TEMPORARY OR PERMANENT REDUCTION, DIVESTITURE, RELINQUISHMENT, OR TERMINATION OF MSK'S OR AN INSTITUTIONAL OFFICIAL'S INSTITUTIONAL INTEREST. 3. BOARDS OF MANAGERS CONFLICT OF INTEREST POLICY (THE "BOARD COI POLICY"). a. THE BOARD COI POLICY APPLIED TO BOARD MEMBERS, OFFICERS, AND OTHER MSK SENIOR LEADERSHIP. INDIVIDUALS COVERED BY THE BOARD COI POLICY WERE REQUIRED TO DISCLOSE FINANCIAL INTERESTS AND RELATIONSHIPS, AS DEFINED BY THE POLICY, ANNUALLY AND ON AN ONGOING BASIS. OTHER ENTITIES IN THE SAME TAX-EXEMPT GROUP HAD OVERLAPPING OFFICERS AND BOARD MEMBERS AS DESCRIBED IN SCHEDULE O; SUCH PERSONS REPORTED FINANCIAL INTERESTS THROUGH THIS OR RELATED PROCESSES. b. THE JOINT COI COMMITTEE WAS RESPONSIBLE FOR DETERMINING WHETHER ANY INTEREST DISCLOSED UNDER THE BOARD COI POLICY GAVE RISE TO A CONFLICT OF INTEREST. THE POLICY REQUIRED THAT THE MEMBERS OF THE JOINT COI COMMITTEE VOTE, WITHOUT THE INDIVIDUAL WITH THE POTENTIAL CONFLICT PRESENT, TO DETERMINE WHETHER A CONFLICT OF INTEREST EXISTED. ALL MEMBERS PARTICIPATING IN THE VOTE WERE REQUIRED TO BE DISINTERESTED WITH RESPECT TO THE TRANSACTION, ARRANGEMENT, OR RELATIONSHIP. c. THE COVERED INDIVIDUAL WITH THE CONFLICT OF INTEREST COULD MAKE A PRESENTATION TO THE JOINT COI COMMITTEE, BUT COULD NOT PARTICIPATE IN OR INFLUENCE THE DISCUSSION OF, OR VOTE ON, THE PROPOSED TRANSACTION, ARRANGEMENT, OR RELATIONSHIP. THE EXISTENCE AND RESOLUTION OF ANY CONFLICT OF INTEREST, ALONG WITH ASSOCIATED DETERMINATIONS MADE AND VOTES TAKEN, WERE REQUIRED TO BE DOCUMENTED IN WRITING. d. FOR ANY TRANSACTION, ARRANGEMENT, OR RELATIONSHIP THAT INVOLVED A CONFLICT OF INTEREST, A CONFLICT MANAGEMENT PLAN COULD BE IMPLEMENTED IF DOING SO WAS IN THE BEST INTERESTS OF MSK. MANAGEMENT PLANS COULD REQUIRE DISCLOSURE, RECUSAL OR OTHER LIMITATION OF ROLE, INDEPENDENT OVERSIGHT AND CONFIDENTIALITY. FORM 990, PART VI, LINE 15 MEMORIAL SLOAN-KETTERING CANCER CENTER IS COMMITTED TO ENSURING THAT ITS EXECUTIVE COMPENSATION PROGRAM ADHERES TO THE ESTABLISHED STANDARDS OF REGULATORY COMPLIANCE AND BEST CORPORATE GOVERNANCE. THE BOARD OF OVERSEERS AND MANAGERS HAS CHARGED THE JOINT HUMAN RESOURCES COMMITTEE (WHICH IS COMPOSED OF INDEPENDENT BOARD MEMBERS WITH NO CONFLICTS OF INTEREST IN REGARD TO EXECUTIVE COMPENSATION) WITH MAKING ALL DECISIONS RELATED TO COMPENSATION FOR OFFICERS AND KEY EMPLOYEES. THE COMMITTEE REVIEWS THE TOTAL COMPENSATION OF THE INDIVIDUALS, INCLUDING BOTH CURRENT AND DEFERRED COMPENSATION, AND ALL EMPLOYEE BENEFITS, ON AN ANNUAL BASIS TO ENSURE THAT THE TOTAL COMPENSATION OF EACH OFFICER AND KEY EMPLOYEE IS REASONABLE. TO ASSIST IN THE COMPLETION OF ITS RESPONSIBILITIES, THE COMMITTEE ENGAGES THE SERVICES OF A NATIONALLY RECOGNIZED CONSULTING FIRM SPECIALIZING IN EXECUTIVE COMPENSATION FOR NOT-FOR-PROFIT HEALTHCARE ORGANIZATIONS. EACH YEAR THE COMMITTEE REVIEWS A COMPREHENSIVE REPORT PREPARED BY THE FIRM THAT INCLUDES MARKET DATA FOR FUNCTIONALLY COMPARABLE ROLES IN COMPARABLE ORGANIZATIONS (I.E., NOT-FOR-PROFIT ACADEMIC/RESEARCH MEDICAL CENTERS, ESPECIALLY THOSE SHARING A MISSION SIMILAR TO MSKCC, WITH OTHER HEALTHCARE SECTORS CONSIDERED ON A SELECTED BASIS) AND SUMMARIZES THE RELATIVE MARKET POSITION OF EACH EXECUTIVE'S TOTAL COMPENSATION. THE LAST REVIEW WAS MARCH 2019, WHICH SET THE COMPENSATION FOR THE PERIOD APRIL 2019 TO mARCH 2020. ADDITIONALLY, A SENIOR MEMBER OF THE CONSULTING FIRM ATTENDS THE COMMITTEE'S MEETINGS TO PROVIDE INFORMATION AND TO RESPOND TO QUESTIONS BY THE MEMBERS OF THE COMMITTEE. COMPENSATION LEVELS ARE ESTABLISHED CONSIDERING THE MARKET DATA, AN ASSESSMENT OF PERFORMANCE, AND OTHER BUSINESS JUDGMENT FACTORS, CONSISTENT WITH MSKCC'S EXECUTIVE COMPENSATION PHILOSOPHY. THE COMMITTEE'S DECISIONS ARE MADE IN THE BEST INTERESTS OF MSKCC AND ARE INTENDED TO ENSURE THE RECRUITMENT AND RETENTION OF KEY EXECUTIVE TALENT, CONSISTENT WITH THE MARKET PRACTICES OF OTHER NOT-FOR-PROFIT HEALTHCARE ORGANIZATIONS OF COMPARABLE SCOPE, MISSION AND COMPLEXITY. ON AN ANNUAL BASIS, THE COMMITTEE PROVIDES THE FULL BOARD WITH AN OVERVIEW OF ITS DETERMINATIONS AND PROCESS. THE COMMITTEE'S REVIEW PROCESS FOLLOWS THE INTERMEDIATE SANCTIONS' GUIDELINES FOR QUALIFYING FOR THE REBUTTABLE PRESUMPTION OF REASONABLENESS UNDER SECTION 4958 OF THE INTERNAL REVENUE CODE OF 1986: - THE COMPENSATION ARRANGEMENT IS APPROVED IN ADVANCE BY AN "AUTHORIZED BODY" OF THE APPLICABLE TAX EXEMPT ORGANIZATION (I.E, THE COMMITTEE, WHICH IS COMPOSED ENTIRELY OF INDIVIDUALS WHO DO NOT HAVE A CONFLICT OF INTEREST WITHIN THE MEANING OF THE REGULATIONS UNDER SECTION 4958). - THE AUTHORIZED BODY OBTAINS AND RELIES UPON "APPROPRIATE DATA AS TO COMPARABILITY" PRIOR TO MAKING ITS DETERMINATION, FOR WHICH COMPARABILITY DATA ARE PROVIDED AND ANALYZED BY SULLIVAN, COTTER AND ASSOCIATES, INC., A WELL-REGARDED EXPERT IN THE AREA OF HEALTHCARE COMPENSATION. - THE COMMITTEE ADEQUATELY DOCUMENTS THE BASIS FOR ITS DETERMINATION CONCURRENTLY WITH MAKING THAT DETERMINATION, AGAIN AS REQUIRED IN THE REGULATIONS. FORM 990, PART VI, LINE 19 THE AUDITED FINANCIAL STATEMENTS OF MEMORIAL SLOAN-KETTERING CANCER CENTER AND ITS AFFILIATES ARE AVAILABLE TO THE PUBLIC UPON REQUEST. IN ADDITION, THE FINANCIAL STATEMENTS CAN BE ACCESSED AT THE FOLLOWING WEB ADDRESS: WWW.DACBOND.COM. THE ORGANIZATION HAS ENGAGED DAC BOND AS OUR INVESTOR RELATIONS AND DISCLOSURE/DISSEMINATION AGENT. THE INFORMATION AVAILABLE ON THIS WEB SITE INCLUDES AUDITED FINANCIAL STATEMENTS, QUARTERLY UNAUDITED FINANCIAL STATEMENTS AND THE BOND OFFERING STATEMENTS FOR ALL DEBT ISSUES. IN ADDITION, COPIES OF THE GROUP 990 AND THE APPLICABLE 990T ARE ALSO AVAILABLE. THE CONFLICT OF INTEREST POLICY IS AVAILABLE TO THE PUBLIC UPON REQUEST AND IT ALSO CAN BE FOUND AT THE FOLLOWING INSTITUTIONAL WEB SITE: WWW.MSKCC.ORG. GOVERNING DOCUMENTS SUCH AS THE ARTICLES OF INCORPORATION AND CORPORATE BY-LAWS ARE NOT AVAILABLE TO THE PUBLIC. FORM 990, PART VII, SECTION B AMOUNTS PAID TO INDEPENDENT CONTRACTORS INCLUDE AMOUNTS FOR SUBCONTRACTORS AS WELL AS REIMBURSABLE EXPENSES. FORM 990, PART XI, LINE 9 CHANGE IN POSTRETIREMENT EXPENSE ($224,929,000) OTHER NON-OPERATING EXPENSES ($21,260,000) TOTAL-OTHER CHANGES IN NET ASSETS ($246,189,000) FORM 990, PART XII, LINE 2 THE FINANCIAL STATEMENTS OF MEMORIAL SLOAN-KETTERING CANCER CENTER AND ITS AFFILIATES ARE AUDITED BY AN INDEPENDENT ACCOUNTING FIRM ON A COMBINED BASIS. THE COMBINED STATEMENTS INCLUDE THE ACCOUNTS OF THE FOLLOWING TAX EXEMPT, SECTION 501 (C) (3), INCORPORATED AFFILIATES: MEMORIAL SLOAN-KETTERING CANCER CENTER (EIN 13-1924236), MEMORIAL HOSPITAL FOR CANCER AND ALLIED DISEASES (EIN 13-1624082), SLOAN-KETTERING INSTITUTE FOR CANCER RESEARCH (EIN 13-1624182), S.K.I. REALTY, INC. (EIN 13-3389586), LOUIS V. GERSTNER JR., GRADUATE SCHOOL OF BIOMEDICAL SCIENCES (EIN 20-2212588), AND MSK INSURANCE US, INC.(MVI) EIN 83-0363317. INCLUDED IN THE GROUP EXEMPTION IS MSKCC PROPERTIES LLC (EIN 35-2464610) WITH MEMORIAL HOSPITAL BEING THE SOLE MEMBER, AND MSKCC PROTON, INC. (EIN 35-2397819). THE CENTER'S FINANCIAL STATEMENTS ARE NOT AUDITED INDEPENDENT OF THE COMBINED. REFER TO SCHEDULE D FOR A RECONCILIATION OF THE 990 TO THE CENTER'S FINANCIAL STATEMENTS. STRATEGIC PLANNING AND COMMUNITY BENEFITS MEMORIAL SLOAN-KETTERING CANCER CENTER AND ITS AFFILIATES AS REPORTED ON A COMBINED BASIS WITH A SEPARATE GROUP 990 FILING UNDER EIN # 91-2154236. MEMORIAL SLOAN-KETTERING CANCER CENTER AND ITS AFFILIATES ARE INTERTWINED WITH COMMUNITY BENEFITS AND FINANCIAL ASSISTANCE ACTIVITIES AS OUTLINED BELOW. MSKCC'S STRATEGIC PLANNING PROCESS INCLUDES DEVELOPING PROGRAMS IN RESPONSE TO CANCER MORBIDITY AND MORTALITY DATA, DEMOGRAPHIC DATA, AND COMMUNITY INPUT IN ACCORDANCE WITH ITS IRS "COMMUNITY HEALTH NEEDS ASSESSMENTS" REQUIREMENTS. THESE FINDINGS ARE USED IN DESIGNING AN IMPLEMENTATION STRATEGY TO PLAN INITIATIVES AND PROGRAMS AIMED AT IMPROVING OUR COMMUNITIES' ACCESS TO CANCER INFORMATION. IN ADDITION, THE ORGANIZATION'S STRATEGIC EFFORTS ARE FOCUSED ON REDUCING THE CRITICAL ISSUE OF CANCER HEALTH DISPARITIES AMONG MINORITY AND MEDICALLY UNDERSERVED POPULATIONS. MSKCC'S INPATIENT HOSPITAL IS LOCATED IN MID-MANHATTAN WITH ADDITIONAL OUTPATIENT TREATMENT CENTERS IN BROOKLYN, LONG ISLAND, WESTCHESTER COUNTY, AND NEW JERSEY. OUR PRIMARY CATCHMENT AREA ENCOMPASSES 23 COUNTIES ACROSS THE FIVE BOROUGHS OF NEW YORK CITY, LONG ISLAND, SOUTHERN NEW YORK STATE, NEW JERSEY, AND SOUTHWESTERN CONNECTICUT. A TOTAL OF 202,108 PATIENTS WERE SEEN AT MSKCC'S FACILITIES IN 2019, INCLUDING 181,768 (89.9 PERCENT) PATIENTS FROM THE TRI-STATE AREA (NY, NJ, CT); 18,918 (9.4 PERCENT) PATIENTS FROM OTHER PARTS OF THE UNITED STATES; AND 1,422 (0.7 PERCENT) PATIENTS FROM OTHER COUNTRIES. THESE PATIENTS ACCOUNTED FOR 25,597 ADMISSIONS TO OUR HOSPITAL WITH 173,702 RELATED PATIENT DAYS AND 839,073 OUTPATIENT VISITS AT OUR COMBINED FACILITIES IN NEW YORK CITY AND THE REGION. SINCE 1987, MSKCC HAS HAD A FINANCIAL ASSISTANCE PROGRAM (FAP) IN PLACE TO ASSIST UNDERINSURED AND UNINSURED PATIENTS WHO ARE EXPERIENCING DIFFICULTIES MEETING THEIR FINANCIAL RESPONSIBILITIES TO MEMORIAL HOSPITAL AND ITS PHYSICIANS. FINANCIAL COUNSELORS WORK WITH PATIENTS AND INSURANCE COMPANIES - INCLUDING MEDICARE AND MEDICAID - TO HELP THE PATIENTS TO ACCESS SERVICES. THOSE WHO DO NOT QUALIFY FOR PUBLICLY AVAILABLE HEALTH INSURANCE, OR WHO ARE UNABLE TO PAY THEIR PORTION OF FEES ABOVE INSURANCE REIMBURSEMENT, MAY OBTAIN HELP THROUGH THE INSTITUTION'S FAP IF THEY ARE ELIGIBLE. THE PREMISE OF THE PROGRAM IS THAT ALL PATIENTS ARE EXPECTED TO CONTRIBUTE TO THEIR CARE BASED ON THEIR FINANCIAL ABILITY. THE FINANCIAL ASSISTANCE PROGRAM EMPLOYS SEVERAL STRATEGIES TO INCREASE PATIENTS' AWARENESS OF THE PROGRAM. DURING THE REGISTRATION PROCESS, FINANCIAL INTERVIEWERS EDUCATE PATIENTS ON THE VARIOUS PROGRAMS AVAILABLE TO THEM, INCLUDING GOVERNMENTAL PROGRAMS AND THE FINANCIAL ASSISTANCE PROGRAMS. MSKCC PERSONNEL SENDS THE FAP BROCHURE WITH THE INITIAL HOSPITAL BILL TO EVERY NEW PATIENT TO MAKE THEM AWARE OF THE CHARITY CARE/FINANCIAL ASSISTANCE PROGRAM. THE FAP IS ALSO MENTIONED IN EVERY PATIENT STATEMENT AND LETTER THAT IS SENT TO A PATIENT. MOREOVER, THE FAP IS MENTIONED IN EVERY COLLECTION LETTER SENT TO PATIENTS BY THE COLLECTION AGENCIES. EVEN AFTER A PATIENT'S ACCOUNT IS SENT TO COLLECTIONS, HE/SHE CAN STILL APPLY FOR FINANCIAL ASSISTANCE. IT IS NEVER TOO LATE TO APPLY FOR FINANCIAL ASSISTANCE AND RETROACTIVE FAP COVERAGE WOULD BE GIVEN IF A PATIENT IS DETERMINED ELIGIBLE FOR ASSISTANCE. INFORMATION ABOUT THE FINANCIAL ASSISTANCE PROGRAM IS ALSO AVAILABLE ON THE INSTITUTION'S WEBSITE AT WWW.MSKCC.ORG/FINANCIAL-ASSISTANCE OR BY CALLING OUR DEDICATED FINANCIAL ASSISTANCE LINE AT (212) 639-3810. A PATIENT MAY ALSO QUALIFY FOR ASSISTANCE EVEN IF HIS/HER INCOME IS GREATER THAN THE THRESHOLD LIMIT. THE INSTITUTION ADJUSTS PATIENTS' INCOME FOR ROUTINE MONTHLY EXPENSES, INCLUDING TAXES, TO DETERMINE, DISPOSABLE INCOME. MSKCC ALSO DEDUCTS A SPECIFIC AMOUNT (DEBT BURDEN) AS MONTHLY CLOTHES AND FOOD ALLOWANCE BASED ON A PATIENT'S FAMILY SIZE IN EVALUATING THE TYPE AND AMOUNT OF ASSISTANCE NEEDED. THE TABLE BELOW ILLUSTRATES THE INCOME GUIDELINES USED. FAMILY SIZE ALLOWED INCOME RESOURCE LEVELS 1 $62,450 $37,875 2 $84,550 $55,500 3 $106,650 $62,535 4 $128,750 $70,688 5 $150,850 $78,848 6 $172,950 $87,000 STRATEGIC PLANNING AND COMMUNITY BENEFITS - CONTINUED MSKCC ENGAGES IN AND SUPPORTS COALITION-BUILDING ACTIVITIES THAT PROMOTE THE HEALTH OF THE COMMUNITIES THE INSTITUTION SERVES. STAFF MEMBERS ARE ENCOURAGED TO SHARE THEIR CLINICAL EXPERTISE AND EXPERIENCE WITH PARTNERING HEALTHCARE FACILITIES AND COMMUNITY ORGANIZATIONS. STAFF MEMBERS SERVE AND PARTICIPATE IN NUMEROUS COMMUNITY GROUPS INCLUDING THE AMERICAN CANCER SOCIETY, THE GREATER NEW YORK HOSPITAL ASSOCIATION, AND MANY HEALTH IMPROVEMENT ADVOCACY GROUPS FOR VARIOUS TYPES OF CANCER. ALTHOUGH THE SIGNIFICANT COST OF STAFF TIME DEVOTED TO THESE ACTIVITIES IS NOT QUANTIFIED BY THE CENTER, THE INSTITUTION CONSIDERS THESE EFFORTS TO COLLABORATE AND BUILD COMMUNITY RESOURCES TO BE OF SIZEABLE COMMUNITY BENEFIT. MSKCC CONDUCTED A COMMUNITY HEALTH NEEDS ASSESSMENT (CHNA) DURING THE SECOND QUARTER OF 2019 TO DETERMINE THE CRITICAL CANCER-RELATED HEALTH NEEDS FACING RESIDENTS IN OUR 23-COUNTY CATCHMENT AREA IN NEW YORK, NEW JERSEY, AND CONNECTICUT. WE ANALYZED CANCER STATISTICS ON INCIDENCE, PREVALENCE, AND MORTALITY. WE ALSO REVIEWED KEY HEALTH TRENDS AMONG CANCER PATIENTS, MULTICULTURAL POPULATIONS, AND THE PUBLIC. TO ENGAGE THE BROAD COMMUNITY IN OUR HEALTH NEEDS ASSESSMENT, MSKCC HELD A SERIES OF COMMUNITY FORUMS IN MANHATTAN (HARLEM), BROOKLYN, LONG ISLAND, WESTCHESTER AND NEW JERSEY AS WELL AS AN ADDITIONAL WEBINAR PLACING SPECIAL FOCUS ON THE HEALTH NEEDS OF THE HISPANIC COMMUNITY. THE FORUMS WERE CONDUCTED TO CONNECT WITH REPRESENTATIVES FROM COMMUNITY-BASED ORGANIZATIONS. THESE PRIVATE, NON-PROFIT, PUBLIC, AND GOVERNMENT AGENCIES WORK TO MEET COMMUNITY NEEDS WITH SERVICES AND RESOURCES THROUGHOUT NEW YORK CITY AND ITS SURROUNDING COMMUNITIES. REPRESENTATIVES FROM 40 COMMUNITY-BASED ORGANIZATIONS AND PARTNERS WHO SERVE A DIVERSE RANGE OF CLIENTS PARTICIPATED IN THESE FORUMS. SERVICES PROVIDED BY THE ORGANIZATIONS INCLUDE CANCER CARE SUPPORT, FOOD, MEDICAL, PSYCHOSOCIAL, IMMIGRATION ASSISTANCE, AND PRIMARY CARE SERVICES. SUMMARY FINDINGS OF MSKCC'S COMMUNITY HEALTH NEEDS ASSESSMENT WERE SENT TO COMMUNITY-BASED ORGANIZATIONS WITH WHOM WE WORK AND INVITED THEIR FEEDBACK. WE ALSO INCORPORATED THE CHNA INTO OUR ANNUAL COMMUNITY SERVICE PLAN (CSP) TO ADDRESS THE IDENTIFIED HEALTH NEEDS. THE CSP WAS DISTRIBUTED TO LOCAL ELECTED OFFICIALS AND OTHER COMMUNITY ORGANIZATIONS. THE CHNA WAS ALSO PUBLISHED TO OUR WEBSITE AT WWW.MSKCC.ORG/COMMUNITYSERVICEPLANS, FOR PUBLIC INSPECTION AND INPUT. WE PUBLISHED THE CHNA IN 2019 WHEN THE ASSESSMENT WAS COMPLETED. WHILE THE NEXT CHNA CYCLE IS IN 2022, MSKCC WILL BE MAKING ANNUAL UPDATES TO ITS COMMUNITY SERVICE PLAN BEGINNING DECEMBER 2020. EDUCATION AND TRAINING ARE KEY COMPONENTS OF MEMORIAL SLOAN KETTERING CANCER CENTER'S MISSION AND IMPORTANT EXAMPLES OF HOW THE INSTITUTION MAKES CONTRIBUTIONS TO THE CARE AND TREATMENT OF CANCER PATIENTS FAR BEYOND ITS OWN WALLS THROUGH WORKFORCE DEVELOPMENT. OUR TRAINING, GRADUATE, AND CONTINUING EDUCATION PROGRAMS PREPARE PHYSICIANS, SCIENTISTS, NURSES, AND TECHNICIANS TO BE LEADERS IN THEIR CHOSEN FIELDS. THESE HEALTHCARE PROVIDERS CAN THEN TAKE THE EXPERTISE GAINED FROM WORKING WITH OUR SPECIALISTS TO OTHER HEALTHCARE INSTITUTIONS AROUND THE COUNTRY AND THROUGHOUT THE WORLD. MSKCC ALSO TRAINS GRADUATE STUDENTS AND POSTDOCTORAL RESEARCHERS WORKING IN MANY AREAS OF BASIC SCIENCE AND TRANSLATIONAL RESEARCH. WHEN THESE YOUNG SCIENTISTS COMPLETE THEIR TRAINING, THEY BRING THE SKILLS OBTAINED IN OUR LABORATORIES INTO THE ACADEMIC COMMUNITY AT LARGE AS WELL AS THE PRIVATE SECTOR. MSKCC SPONSORS SEVERAL PROGRAMS THAT GIVE MEDICAL STUDENTS, UNDERGRADUATES, AND HIGH SCHOOL STUDENTS THE OPPORTUNITY TO WORK AT THE INSTITUTION DOING CLINICAL AND LABORATORY RESEARCH. THROUGH THESE PROGRAMS, MEMORIAL SLOAN KETTERING CANCER CENTER STRIVES TO INCREASE THE PIPELINE OF SCIENTISTS AND PHYSICIANS WORKING IN ONCOLOGY. MSKCC'S OFFICE OF DIVERSITY PROGRAMS IN CLINICAL CARE, RESEARCH, AND TRAINING (ODP) PROVIDES FUNDING TO ENCOURAGE INTEREST IN PURSUING CAREERS IN THE FIELD OF ONCOLOGY FOR MEMBERS OF MINORITY GROUPS WHO ARE UNDERREPRESENTED IN MEDICINE AND WISH TO PARTICIPATE IN THE NATIONAL CANCER INSTITUTE'S MEDICAL STUDENTS SUMMER FELLOWSHIP PROGRAM. THE ODP ALSO COORDINATES A SIX-WEEK SUMMER EXPOSURE PROGRAM TO EXPOSE UNDERREPRESENTED MINORITY HIGH SCHOOL STUDENTS TO CAREERS IN MEDICINE AND RESEARCH. MEMORIAL SLOAN KETTERING CANCER CENTER UTILIZED $280.0M OF THE INSTITUTION'S RESOURCES DURING 2019 TO SUPPORT ITS EDUCATION AND TRAINING MISSION, WHICH WE SEE AS VITAL, GIVEN OUR LEADERSHIP ROLE IN CANCER CARE TREATMENT AND RESEARCH. $66.9M OF THE AMOUNT WAS SPONSORED BY GOVERNMENTAL AND OTHER REVENUE SOURCES AND $213.1M FROM THE INSTITUTION'S GENERAL FUND. MSKCC FOCUSES ON MULTIDISCIPLINARY CARE, WHERE EXPERTS FROM MANY FIELDS OF MEDICINE COME TOGETHER TO DEVELOP THE BEST TREATMENTS FOR INDIVIDUAL PATIENTS AND FOR THE TREATMENT OF PATIENTS WITH ALL TYPES OF CANCER. THIS HAS ALLOWED US TO BE AT THE FOREFRONT OF DEVELOPING TREATMENTS THAT ARE MORE EFFECTIVE AT TREATING CANCER, WHILE AT THE SAME TIME SPARING MANY PATIENTS FROM THE MOST SERIOUS SIDE EFFECTS OF TREATMENT. OUR BASIC AND TRANSLATIONAL RESEARCHERS HAVE MADE MANY SIGNIFICANT CONTRIBUTIONS TO THE SCIENTIFIC COMMUNITY'S UNDERSTANDING OF CANCER BIOLOGY AND CANCER GENETICS AS WELL AS TO RELATED FIELDS -- CELL BIOLOGY, MOLECULAR BIOLOGY, STRUCTURAL BIOLOGY, DEVELOPMENTAL BIOLOGY, MOLECULAR PHARMACOLOGY AND CHEMISTRY, IMMUNOLOGY, COMPUTATIONAL BIOLOGY, AND DRUG DEVELOPMENT. GENES FIRST IDENTIFIED IN OUR LABORATORIES ARE NOW THE FOCUS OF INTENSE RESEARCH IN OTHER LABORATORIES AROUND THE WORLD. DRUGS, MONOCLONAL ANTIBODIES, AND OTHER AGENTS FIRST DEVELOPED IN OUR LABORATORIES HAVE GONE ON TO GAIN REGULATORY APPROVAL FOR TREATING PATIENTS WORLDWIDE. RECENT EXPANSION OF OUR LABORATORY SPACE HAS ALLOWED US TO GROW OUR RESEARCH EFFORTS SO THAT GOING FORWARD WE CAN CONTINUE TO MAKE DISCOVERIES THAT WILL CHANGE THE WAY THE WORLD UNDERSTANDS CANCER AND AID IN THE DEVELOPMENT OF BETTER TREATMENTS FOR CANCER PATIENTS EVERYWHERE. IN 2019, MEMORIAL SLOAN KETTERING CANCER CENTER SPENT $552.3M IN SUPPORT OF ITS RESEARCH MISSION, OF WHICH $214.0M WAS SPONSORED BY GOVERNMENTAL AND OTHER NON-PROFIT ORGANIZATIONS, $149.5M FROM PHILANTHROPY, AND $188.7M FROM THE INSTITUTION'S FUNDS. .. . PROSTATE CANCER CLINICAL TRIALS 1275 YORK AVE NEW YORK NY 10065 352506225 CANCER CARE DE 743000 5656000 MSKCC MEMORIAL MEDICAL CARE PC 1275 YORK AVENUE NEW YORK NY 10065 352491455 CANCER CARE NY 501 (C )3 10 MSKCC true MEM RADIATION ONCOL 1275 YORK AVE NY NY 10065 133237927 HEALTH CARE NY MEM RELATED 30180227 0 false 0 true 0.01000 MEM PATHOLOGY GROUP 1275 YORK AVE NY NY 10065 133365998 HEALTH CARE NY MEM RELATED 52574945 0 false 0 true 0.01000 MEM ANESTHESIOLOGY 1275 YORK AVE NY NY 10065 133367135 HEALTH CARE NY MEM RELATED 63919019 0 false 0 true 0.01000 MEM PEDIATRICS GRP 1275 YORK AVE NY NY 10065 133346908 HEALTH CARE NY MEM RELATED 10585668 0 false 0 true 0.01000 MEM NEUROLOGY GROUP 1275 YORK AVE NY NY 10065 133399377 HEALTH CARE NY MEM RELATED 12547803 0 false 0 true 0.01000 MEM PSYCHIATRY GRP 1275 YORK AVE NY NY 10065 133430629 HEALTH CARE NY MEM RELATED 4660610 0 false 0 true 0.01000 MSK NASSAU 1275 YORK AVE NY NY 10065 611904151 HEALTH CARE NY MEM RELATED 5566382 0 false 0 true 0.01000 MSK AT MERCY 1275 YORK AVE NY NY 10065 133954858 HEALTH CARE NY MEM RELATED 2567844 0 false 0 true 0.01000 MEM INFECT DISEASE 1275 YORK AVE NY NY 10065 133278582 HEALTH CARE NY MEM RELATED 2964551 0 false 0 true 0.01000 MSK SURGERY GROUP 1275 YORK AVE NY NY 10065 134010372 HEALTH CARE NY MEM RELATED 178264178 0 false 0 true 0.01000 MSK HAUPPAUGE 1275 YORK AVE NY NY 10065 134059247 HEALTH CARE NY MEM RELATED 5983017 0 false 0 true 0.01000 INTERGRATIVE MED 1275 YORK AVE NY NY 10065 542092060 HEALTH CARE NY MEM RELATED 1439310 0 false 0 true 0.01000 MSK-REGIONAL NETWK 1275 YORK AVE NY NY 10065 020594889 HEALTH CARE NY MEM RELATED 16296606 0 false 0 true 0.01000 MSK BASKING RIDGE 1275 YORK AVE NY NY 10065 593801080 HEALTH CARE NY MEM RELATED 14762319 0 false 0 true 0.01000 MEM URGENT CARE GRP 1275 YORK AVE NY NY 10065 651263291 HEALTH CARE NY MEM RELATED 7033001 0 false 0 true 0.01000 MEM CLN GENETICS 1275 YORK AVE NY NY 10065 651263292 HEALTH CARE NY MEM RELATED 407477 0 false 0 true 0.01000 MEM DEVELOP CHEMO 1275 YORK AVE NY NY 10065 133278548 HEALTH CARE NY MEM RELATED 5710154 0 false 0 true 0.01000 MEM MEDICAL CONSULT 1275 YORK AVE NY NY 10065 133278550 HEALTH CARE NY mem RELATED 8016528 0 false 0 true 0.01000 MSK CLINIC PRACTICE 1275 YORK AVE NY NY 10065 510616510 HEALTH CARE NY MEM RELATED 14475220 0 false 0 true 0.01000 RALPH LAUREN CTR 1275 YORK AVE NY NY 10065 350577172 HEALTH CARE NY MEM RELATED 60841 0 false 0 true 0.01000 MEM CLINICAL PHY 1275 YORK AVE NY NY 10065 133278556 HEALTH CARE NY MEM RELATED 2193140 0 false 0 true 0.01000 MEM SOLID TUMOR GRP 1275 YORK AVE NY NY 10065 133278578 HEALTH CARE NY MEM RELATED 43312698 0 false 0 true 0.01000 MEM DERMATOLOGY GRP 1275 YORK AVE NY NY 10065 133278581 HEALTH CARE NY MEM RELATED 8200750 0 false 0 true 0.01000 MEM ENDOCRINE GRP 1275 YORK AVE NY NY 10065 133278583 HEALTH CARE NY MEM RELATED 3683889 0 false 0 true 0.01000 GASTROENTEROLOGY 1275 YORK AVE NY NY 10065 133278574 HEALTH CARE NY MEM RELATED 9424041 0 false 0 true 0.01000 MEM HEMATOLOGYLYMP 1275 YORK AVE NY NY 10065 133278575 HEALTH CARE NY MEM RELATED 20500813 0 false 0 true 0.01000 MEM PULMONARY FUNC 1275 YORK AVE NY NY 10065 133304834 HEALTH CARE NY MEM RELATED 4869170 0 false 0 true 0.01000 MEM CARDIOPULMONARY 1275 YORK AVE NY NY 10065 133278552 HEALTH CARE NY MEM RELATED 6184320 0 false 0 true 0.01000 MSKCC RADIOLOGY GRP 1275 YORK AVE NY NY 10065 133375559 HEALTH CARE NY MEM RELATED 89907012 0 false 0 true 0.01000 MEM NUCLEAR MED 1275 YORK AVE NY NY 10065 133278580 HEALTH CARE NY MEM RELATED 9150586 0 false 0 true 0.01000 MSK HARRISON 1275 YORK AVE NY NY 10065 300831483 HEALTH CARE NY MEM RELATED 18032673 0 false 0 true 0.01000 MSK BERGEN 1275 YORK AVE NY NY 10065 611791803 HEALTH CARE NY MEM RELATED 8202328 0 false 0 true 0.01000 MSK MONMOUTH 1275 YORK AVE NY NY 10065 300937486 HEALTH CARE NY MEM RELATED 14990131 0 false 0 true 0.01000 PANAKEIA ENERGY 10000 MEMORIAL DR HOUSTON TX 77024 800891961 INVESTMENT DE MSK ECLUDED UNDER 512 -8556675 10930826 false -1416878 true 0.99200 BTS LIQUIDATING LLC 1430 BROADWAY NY NY 10018 262602952 INVESTMENT NY MSK EXCLUDED UNDER 512 -134781 1151558 false 0 true 0.70000 CHARITABLE REMAINDER TRUSTS 184 N/A TWO SIGMA US ALL CAP 89 NEXUS WAY CAMANA BAY GRAND CAYMAN CJ KY1-9007 INVESTMENT CJ MSK C 28190712 135177205 1.00000 true AXAR OFFSHORE FUND LTD PO BOX 309 UGLAND HOUSE GRAND CAYMAN CJ KY1-1104 INVESTMENT CJ MSK C 4241767 133664762 0.54220 true false false false false false false false false false true true true false false false false false false MEMORIAL HOSPITAL FOR CANCER & ALLIED DISEASE L 605611000 COST SLOAN-KETTERING INSTITUTE FOR CANCER RESEARCH L 161774000 COST SKI REALTY INC L 4958000 COST LOUIS V GERSTNER JR GRADUATE SCHOOL L 84000 COST MEMORIAL HOSPITAL FOR CANCER & ALLIED DISEASE M 12846000 COST SLOAN-KETTERING INSTITUTE FOR CANCER RESEARCH M 8592000 COST SKI REALTY INC K 15194000 cost